Hematology Oncology Therapy 3E

The essential therapy guide to cancer, hematologic disorders, and supportive care―updated with the latest treatment regimens

Hematology-Oncology Therapy, Third Edition, is an up-to-date, comprehensive therapy guide that delivers more than 800 treatment regimens in a succinct, uniform format. Supported by the latest practice guidelines, peer-reviewed literature, and insights from experts in the field, this peerless resource integrates extensive information critical to both office- and hospital-based practice of hematology and oncology.

Hematology-Oncology Therapy is divided into four sections:

Cancer Regimens: Covers administration, toxicity, dose modification, monitoring, supportive care, and the efficacy of commonly used and recently approved therapeutic regimens, and includes expert opinion and critical information on epidemiology, pathology, work-up, and staging, as well as survival data

Antiemetics, Growth Factors, Dose Modification and Drug Preparation: Provides in-depth coverage of antiemetics, growth factors, and the administration and formulation of anti-cancer drugs

Supportive Care, Complications, and Screening (online): Offers thorough coverage of topics commonly encountered in clinical hematology-oncology practice

Selected Hematologic Diseases (online): provides an authoritative guide to therapy for principal diseases in consultative hematology

The entire content is now online at AccessHemOnc.com. The online platform created for the third edition will be continually updated, including newly approved regimens.

A Doody’s Core Title for 2022!

Editorial Reviews

From the Publisher
Michael Boyiadzis, MD, Associate Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, UPMC Cancer Pavilion.

Antonio Tito Fojo, MD, PhD, Professor of Medicine, Columbia University Medical Center Director, Neuroendocrine Cancers Co-Director, Adrenal Center Co-Director, Columbia/James J. Peters VA Hospital Cancer Center

David R. Kohler, PharmD, Pharmacy Department, National Institutes of Health

About the Author
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide

Michael Boyiadzis, MD, is an associate professor of medicine, Department of Medicine, Division of Hematology/Oncology, UPMC Cancer Pavilion.

Antonio Tito Fojo, MD, PhD, is a professor of medicine, Columbia University Medical Center Director, Neuroendocrine Cancers Co-Director, Adrenal Center Co-Director, Columbia/James J. Peters VA Hospital Cancer Center.